title: [Results after treatment with sildenafil citrate in 100 patients with erectile dysfunction].
abstract: OBJECTIVE
  In order to know the efficiency, tolerance and acceptance of Sildenafil Citrate in our area as a new treatment for Eréctil Dysfunction (E.D.).
  
  
  METHODS
  We include 100 patients with E.D. who were assisted in our medical office from November 1998 to February 2000 to evaluate them according to several predeterminated variables.
  
  
  RESULTS
  The positive response index (E.D. improvement) was 69.9%. We only found side effects in 11.8% (headache 5.4%, flushing 4.3%, diarrhea/blurred vision 2.2%). The most widely used dose was 50 mgrs (65.6%). Only 50.5% of the patients had enough information about Sildenafil. The highest positive response index corresponded to the mild E.D. (76.1%). Also the best results were achieved with the mixed and psychological etiology (74.1%). The Sildenafil treatment was rejected (fear or its price) by the 46.2% of the patients.
  
  
  CONCLUSIONS
  The Sildenafil Citrate is an effective treatment for the E.D. It hardly has any side effects. The 50 mgrs dose got the best results. Almost half of the patients complained about an insufficient information on this pharmaceutical. Sildenafil got a good response even when there were risk associated factors of E.D.
authors.affiliation: Servicio de Urología, Hospital Montecelo, Pontevedra.
authors.forename: M
authors.initials: M
authors.lastname: Varela Salgado
authors.forename: C
authors.initials: C
authors.lastname: Cadarso Suárez
authors.forename: V
authors.initials: V
authors.lastname: García Riestra
authors.forename: J C
authors.initials: JC
authors.lastname: Meirás Barreiro
authors.forename: J A
authors.initials: JA
authors.lastname: Pazos Riveiro
authors.forename: F
authors.initials: F
authors.lastname: Llovo Taboada
mesh_terms: D000328:Adult; D000368:Aged; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
chemical_list: D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate
vernacular_title: Resultados tras el tratamiento con Citrato de Sildenafilo en 100 pacientes con disfunción eréctil.